Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Shares, $0.01 par value
-
Shares outstanding
-
29,579,010
-
Total 13F shares
-
6,434,689
-
Share change
-
+916,739
-
Total reported value
-
$80,230,199
-
Price per share
-
$12.47
-
Number of holders
-
79
-
Value change
-
+$11,333,847
-
Number of buys
-
43
-
Number of sells
-
32
Institutional Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) as of Q3 2023
As of 30 Sep 2023,
abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) was held by
79 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,434,689 shares.
The largest 10 holders included
MORGAN STANLEY, 1607 Capital Partners, LLC, Allspring Global Investments Holdings, LLC, RPO LLC, WOLVERINE ASSET MANAGEMENT LLC, NEEDHAM INVESTMENT MANAGEMENT LLC, Cornerstone Advisors, LLC, AQR Arbitrage LLC, Saba Capital Management, L.P., and Logan Stone Capital, LLC.
This page lists
79
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.